{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:50:16Z","timestamp":1740138616870,"version":"3.37.3"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ijid.2022.05.026","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T17:27:23Z","timestamp":1652290043000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Long-term serological SARS-CoV-2 IgG kinetics following mRNA COVID-19 vaccine: real-world data from a large cohort of healthcare workers"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3925-242X","authenticated-orcid":false,"given":"Joana","family":"Oliveira-Silva","sequence":"first","affiliation":[]},{"given":"Teresa","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Cristiana","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Batista-Silva","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9785-857X","authenticated-orcid":false,"given":"Ricardo","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"Gilberto","family":"Marques","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4011-1173","authenticated-orcid":false,"given":"Vania","family":"Pacheco","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1127-0666","authenticated-orcid":false,"given":"Tiago","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Alexandre","family":"Afonso","sequence":"additional","affiliation":[]},{"given":"V\u00edtor","family":"Pinheiro","sequence":"additional","affiliation":[]},{"given":"Luc\u00edlia","family":"Ara\u00fajo","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Antunes","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2022.05.026_bib0001","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa2114255","article-title":"Protection of BNT162b2 vaccine booster against COVID-19 in Israel","volume":"385","author":"Bar-On","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.05.026_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines9101092","article-title":"Waning of IgG, total and neutralizing antibodies 6 months post-vaccination with BNT162b2 in healthcare workers","volume":"9","author":"Bayart","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ijid.2022.05.026_bib0003","doi-asserted-by":"crossref","first-page":"eabf7517","DOI":"10.1126\/scitranslmed.abf7517","article-title":"T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals","volume":"13","author":"Bilich","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2022.05.026_bib0004","first-page":"144","article-title":"Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection","volume":"4","author":"Bottino","year":"2021","journal-title":"Antib Ther"},{"key":"10.1016\/j.ijid.2022.05.026_bib0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00265-010-1029-6","article-title":"AIC model selection and multimodel inference in behavioral ecology: some background, observations, and comparisons","volume":"65","author":"Burnham","year":"2011","journal-title":"Behav Ecol Sociobiol"},{"key":"10.1016\/j.ijid.2022.05.026_bib0006","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/TP.0000000000003784","article-title":"Poor anti-SARS-CoV-2 humoral and T-cell responses after 2 injections of mRNA vaccine in kidney transplant recipients treated with Belatacept","volume":"105","author":"Chavarot","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.ijid.2022.05.026_bib0007","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41577-021-00550-x","article-title":"Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection","volume":"21","author":"Cromer","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijid.2022.05.026_bib0008","doi-asserted-by":"crossref","first-page":"eabf4063","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ijid.2022.05.026_bib0009","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41591-021-01325-6","article-title":"Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2","volume":"27","author":"Ebinger","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2022.05.026_bib0010","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","article-title":"Evolution of antibody immunity to SARS-CoV-2","volume":"591","author":"Gaebler","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2022.05.026_bib0011","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/annrheumdis-2021-220272","article-title":"Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort","volume":"80","author":"Geisen","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijid.2022.05.026_bib0012","doi-asserted-by":"crossref","first-page":"eabi6950","DOI":"10.1126\/sciimmunol.abi6950","article-title":"Distinct antibody and memory B cell responses in SARS-CoV-2 na\u00efve and recovered individuals following mRNA vaccination","volume":"6","author":"Goel","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ijid.2022.05.026_bib0013","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(21)02046-8","article-title":"Considerations in boosting COVID-19 vaccine immune responses","volume":"398","author":"Krause","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2022.05.026_bib0014","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/vaccines9111241","article-title":"Robust SARS-CoV-2 antibody responses in Asian COVID-na\u00efve subjects 180 days after two doses of BNT162b2 mRNA COVID-19 vaccine","volume":"9","author":"Lau Phua","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ijid.2022.05.026_bib0015","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months","volume":"385","author":"Levin","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.05.026_bib0016","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3390\/diagnostics11071135","article-title":"Evaluation of anti-SARS-Cov-2 S-RBD IgG antibodies after COVID-19 mRNA BNT162b2 vaccine","volume":"11","author":"Lo Sasso","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ijid.2022.05.026_bib0017","article-title":"Dynamics of antibody response to BNT162b2 vaccine after six months\u00a0: a longitudinal prospective study","volume":"10","author":"Naaber","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.ijid.2022.05.026_bib0018","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.2041-210x.2012.00261.x","article-title":"A general and simple method for obtaining R 2 from generalized linear mixed-effects models","volume":"4","author":"Nakagawa","year":"2013","journal-title":"Methods Ecol Evol"},{"key":"10.1016\/j.ijid.2022.05.026_bib0019","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.vaccine.2021.12.014","article-title":"Humoral response to the SARS-CoV-2 BNT162b2 mRNA vaccine: real-world data from a large cohort of healthcare workers","volume":"40","author":"Oliveira-Silva","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2022.05.026_bib0020","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.jinf.2021.06.024","article-title":"Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers","volume":"83","author":"Salvagno","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2022.05.026_bib0021","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5937\/jomb0-33999","article-title":"Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers","volume":"41","author":"Salvagno","year":"2022","journal-title":"J Med Biochem"},{"key":"10.1016\/j.ijid.2022.05.026_bib0022","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(21)02183-8","article-title":"Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study","volume":"398","author":"Tartof","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2022.05.026_bib0023","first-page":"1077","article-title":"Robust neutralizing antibody responses 6 months post vaccination with BNT162b2: a prospective study in 308 healthy individuals","volume":"11","author":"Terpos","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.ijid.2022.05.026_bib0024","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.05.026_bib0025","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jinf.2021.06.017","article-title":"Waning antibodies in SARS-CoV-2 na\u00efve vaccinees: results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers","volume":"83","author":"Tr\u00e9-Hardy","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2022.05.026_bib0026","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.3390\/cells10081952","article-title":"Differences in the concentration of anti-SARS-CoV-2 IgG antibodies post-COVID-19 recovery or post-vaccination","volume":"10","author":"Tretyn","year":"2021","journal-title":"Cells"},{"first-page":"1","year":"2020","series-title":"Vaccines and related biological products advisory committee meeting, December 17, 2020. FDA Briefing Document Moderna COVID-19 Vaccine","key":"10.1016\/j.ijid.2022.05.026_bib0027"},{"key":"10.1016\/j.ijid.2022.05.026_bib0028","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.2021.19996","article-title":"Durability of antibody levels after vaccination with mRNA SARS-CoV-2 vaccine in individuals with or without prior infection","volume":"326","author":"Zhong","year":"2021","journal-title":"JAMA"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222002892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222002892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T14:31:19Z","timestamp":1715437879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971222002892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":28,"alternative-id":["S1201971222002892"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2022.05.026","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term serological SARS-CoV-2 IgG kinetics following mRNA COVID-19 vaccine: real-world data from a large cohort of healthcare workers","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2022.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}